Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
NYSEARCA: TBXU · Real-Time Price · USD
36.95
-0.96 (-2.53%)
Oct 2, 2026, 4:00 PM EDT - Market closed
| Assets | $2.77M |
| Expense Ratio | 0.98% |
| PE Ratio | n/a |
| Shares Out | 75,001 |
| Dividend (ttm) | $0.76 |
| Dividend Yield | 2.07% |
| Ex-Dividend Date | Sep 22, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 37.91 |
| Day's Range | n/a |
| 52-Week Low | 25.71 |
| 52-Week High | 45.88 |
| Beta | n/a |
| Holdings | 11 |
| Inception Date | Oct 1, 2025 |
About TBXU
Fund Home PageThe Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.
Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSE Arca
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index
Top 10 Holdings
245.13% of assets| Name | Symbol | Weight |
|---|---|---|
| BIOEW5 SWAP ASSET LEG | n/a | 59.66% |
| BIOEW5 SWAP ASSET LEG | n/a | 44.07% |
| BIOEW5 SWAP ASSET LEG | n/a | 40.10% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 38.83% |
| Amgen Inc. | AMGN | 12.17% |
| Gilead Sciences, Inc. | GILD | 11.58% |
| Vertex Pharmaceuticals Incorporated | VRTX | 11.10% |
| argenx SE | ARGX | 10.70% |
| Regeneron Pharmaceuticals, Inc. | REGN | 10.63% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | n/a | 6.30% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2026 | $0.14204 | Sep 29, 2026 |
| Jun 23, 2026 | $0.11101 | Jun 30, 2026 |
| Mar 24, 2026 | $0.09893 | Mar 31, 2026 |
| Dec 23, 2025 | $0.10111 | Dec 31, 2025 |
| Dec 10, 2025 | $0.31143 | Dec 17, 2025 |
Performance
TBXU had a total return of 42.13% in the past year, including dividends. Since the fund's inception, the average annual return has been 40.66%.
News
Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs
New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...
1 year ago - GlobeNewsWire